ChemLifeIntel
Access

Broncochem Cold & Flu Syrup Kids

TRACKED

combination medicine

CASHSN30049099
THERAPEUTIC AREAS
MOLECULE INTELLIGENCE SNAPSHOTlive
0
Manufacturers monitored
2
Intelligence briefs
0
Active regulatory actions
1
HSN code

INTELLIGENCE

Showing 2 of 2 briefs for Broncochem Cold & Flu Syrup Kids
REGULATORY INTELLIGENCE·Recall

Global Corporation Initiates Class II Recall of Broncochem Cold & Flu Syrup Kids Due to API Stability Failures

Global Corporation has initiated a Class II recall of 9,831 bottles of Broncochem Cold & Flu Syrup Kids due to stability testing failures for Phenylephrine HCl and/or Chlorpheniramine Maleate. This voluntary action, impacting nationwide U.S. distribution, underscores critical risks in contract manufacturing oversight and API quality control. Procurement and regulatory teams must reassess supplier qualification and post-market surveillance protocols to mitigate similar supply chain disruptions.

90-Day Activity
MKMeera Krishnan· Senior Regulatory Intelligence Analyst
2024-03-20
REGULATORY INTELLIGENCE·Warning Letter

FDA Regulatory Findings Highlight Stability Failures for Global Corporation's Broncochem Cold & Tea

Global Corporation faces significant FDA regulatory findings concerning Broncochem Cold & Tea, stemming from critical stability testing failures for Phenylephrine HCl and/or Chlorpheniramine Maleate. This Class II recall, impacting 2,345 boxes nationwide, underscores severe quality control vulnerabilities. Procurement and regulatory teams must assess their supply chain resilience for these common APIs and prepare for heightened FDA oversight and potential further enforcement actions.

90-Day Activity
CMCatherine Morrow· Senior Regulatory Intelligence Analyst
2024-03-20